Phosphate Unit Converter

Phosphate Unit Converter

Convert serum phosphate between mg/dL, mmol/L and mg/L — and see why the factor uses the atomic weight of phosphorus rather than that of phosphate.

Phosphate converter

Mass ⇄ molar
mg/dL × 0.322854 = mmol/L. The factor is derived from elemental phosphorus, 30.97 Da.
Adult interval. Children and adolescents run considerably higher — a phosphate that would be abnormal in an adult is normal during growth — so use a paediatric range where it applies.
1.13mmol/LExample

Serum phosphate 3.5 mg/dL

Formula and conversion factors

mmol/L = mg/dL × 0.322854
mg/dL = mmol/L ÷ 0.322854
mg/L = mg/dL × 10
0.322854
derived from the atomic weight of elemental phosphorus, 30.9738 Da
not PO₄
laboratories report inorganic phosphate as elemental phosphorus, so the formula mass of the phosphate ion, near 95 Da, must not be used — it would understate the molar result threefold
mg/L
ten times the mg/dL figure, because a decilitre is 100 mL
age
the reference interval is markedly higher in children and adolescents than in adults, and falls to the adult range only after skeletal maturity

Worked example

Serum phosphate 3.5 mg/dL
3.5 × 0.322854 = 1.13 mmol/L
3.5 × 10 = 35.0 mg/L
Within the adult interval of 0.80–1.45 mmol/L, which is 2.48–4.49 mg/dL

Serum phosphate across the three units

mg/dLmmol/Lmg/L
1.00 — severe hypophosphataemia0.3210.0
2.48 — typical lower limit0.8024.8
3.501.1335.0
4.49 — typical upper limit1.4544.9
6.001.9460.0
8.002.5880.0
The mmol/L column is the mg/dL figure multiplied by 0.322854, a factor derived from elemental phosphorus. A factor built from the phosphate ion would give roughly a third of these molar values.

Why the elemental phosphorus convention matters

SpeciesMass usedmg/dL → mmol/L factor
What laboratories actually reportElemental phosphorus (P)30.97 Da0.322854 — correct
A plausible but wrong assumptionPhosphate ion (PO₄³⁻)94.97 Da0.105 — understates the molar result about threefold
Another wrong assumptionHydrogen phosphate (HPO₄²⁻)95.98 Da0.104 — same error
Serum inorganic phosphate exists mostly as a mixture of HPO₄²⁻ and H₂PO₄⁻ whose proportions shift with pH, so no single phosphate species has a fixed mass. Reporting the phosphorus content sidesteps that entirely.

Phosphorus, not phosphate — and why the distinction is not pedantry

Serum phosphate is reported in mg/dL in the United States and in mmol/L elsewhere, with a factor of 0.322854 between them. A phosphate of 3.5 mg/dL is 1.13 mmol/L. That factor is derived from the atomic weight of elemental phosphorus, 30.9738 daltons, and not from the mass of the phosphate ion, and the reason is a genuine and frequent source of confusion rather than a technicality.

Although the test is universally called phosphate, what the laboratory measures and reports is the phosphorus content of the inorganic phosphate in the sample. Inorganic phosphate in serum is not one species: it is a pH-dependent mixture of hydrogen phosphate and dihydrogen phosphate, so there is no single molecular mass that could be used. Expressing the result as elemental phosphorus removes that ambiguity. Anyone who derives a conversion factor from the formula mass of PO₄, near 95 daltons, will produce a molar value roughly a third of the true one, and the error is silent because the number still looks plausible.

Interpretation depends heavily on age and on renal function. Children and adolescents run substantially higher phosphate concentrations than adults throughout skeletal growth, and applying an adult interval to a child manufactures abnormal results. In adults the commonest cause of a high phosphate is reduced renal excretion in chronic kidney disease, where phosphate is managed as part of mineral and bone disorder alongside calcium, PTH and vitamin D rather than as an isolated number.

A low phosphate is often the more urgent finding and is regularly missed. Refeeding after starvation, the treatment of diabetic ketoacidosis, alcohol misuse, phosphate binders and renal phosphate wasting all drive it down, and severe hypophosphataemia below roughly 0.32 mmol/L causes respiratory muscle weakness, rhabdomyolysis and haemolysis. Falsely high results are also worth excluding: haemolysis and delayed separation of the sample release intracellular phosphate and can prompt treatment of an artefact.

Frequently asked questions

How do I convert phosphate from mg/dL to mmol/L?

Multiply by 0.322854. A phosphate of 3.5 mg/dL is 1.13 mmol/L. To go the other way, divide the mmol/L figure by 0.322854.

Why is the factor based on phosphorus and not on phosphate?

Laboratories report the phosphorus content of inorganic phosphate, so the atomic weight of P, 30.97 Da, is the right mass to use. Serum phosphate is a pH-dependent mixture of hydrogen and dihydrogen phosphate with no single molecular mass, which is why the phosphorus convention exists. Using the formula mass of PO₄, near 95 Da, understates the molar result about threefold.

Is a phosphate of 5 mg/dL abnormal?

In an adult it is above the usual interval and suggests reduced renal excretion or a spurious result from haemolysis. In a growing child or adolescent it can be entirely normal, because the paediatric interval runs considerably higher. The age-appropriate range has to be applied before the number means anything.

When is a low phosphate urgent?

Below roughly 0.32 mmol/L, about 1.0 mg/dL, hypophosphataemia causes respiratory muscle weakness, rhabdomyolysis and haemolysis and needs replacement rather than observation. Refeeding after starvation and the treatment of diabetic ketoacidosis are the classic settings, and phosphate should be monitored through both.

Can a phosphate result be falsely high?

Yes. Haemolysis and delayed separation of the sample release phosphate from red cells and raise the measured value. A high phosphate that does not fit the clinical picture or the renal function should be repeated on a properly handled sample.

Related calculators

References

  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1–59.
  2. Felsenfeld AJ, Levine BS. Approach to treatment of hypophosphatemia. Am J Kidney Dis. 2012;60(4):655–661.
  3. Wagner CA. The basics of phosphate metabolism. Nephrol Dial Transplant. 2024;39(2):190–201.